Pamplona Capital Buys Majority Stake In Generic-Drug Maker
London- and New York-based private equity firm Pamplona Capital Management LLP said Wednesday that it has acquired a majority stake in global generic-drug maker Alvogen for an undisclosed amount....To view the full article, register now.
Already a subscriber? Click here to view full article